KATHLEEN HERSHON: Open Payments
NPI 1114366507 · NORTHAMPTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$42,493 in 88 payments from 9 companies in 2025. Trend: 2023 $2,056 · 2024 $1,898 · 2025 $42,493
Speaker / faculty: $29,320Consulting: $7,015Travel & lodging: $3,685Food & beverage: $2,304Education: $169
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 26 | $19,697 |
| Teva Pharmaceuticals USA, Inc. | 13 | $11,207 |
| E.R. Squibb & Sons, L.L.C. | 16 | $10,997 |
| Vanda Pharmaceuticals Inc. | 16 | $186 |
| Otsuka America Pharmaceutical, Inc. | 6 | $118 |
| Axsome Therapeutics, Inc. | 4 | $115 |
| Alkermes, Inc. | 4 | $95 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $31 |
Products named: SPRAVATO, UZEDY, COBENFY, FANAPT, Auvelity, AUSTEDO XR, ARISTADA, REXULTI.
Industry payments across MA — which companies pay providers there.
